alexa Is Kawasaki Disease a Side Effect of Vaccination as Well? | OMICS International
ISSN: 2157-7560
Journal of Vaccines & Vaccination
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Is Kawasaki Disease a Side Effect of Vaccination as Well?

Ibrahim Ece1*, Sinan Akbayram2, Kaan Demiroren2 and Abdurrahman Uner1

1Department of Pediatric Cardiology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey

2Department of Pediatrics, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey

*Corresponding Author:
Ibrahim Ece
Department of Pediatric Cardiology
Yuzuncu Yil University
Faculty of Medicine, Van, Turkey
Tel: + 904322166335
Fax: +904322167519
E-mail: [email protected]

Received Date: March 16 2014; Accepted Date: May 21 2014; Published Date: May 24 2014

Citation: Ece I, Akbayram S, Demiroren K, Uner A (2014) Is Kawasaki Disease a Side Effect of Vaccination as Well?. J Vaccines Vaccin 5:234. doi: 10.4172/2157-7560.1000234

Copyright: © 2014 Ece I et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Vaccines & Vaccination

Abstract

Different subtypes of vasculitis have been reported after vaccination in adults. However, only one case of Kawasaki disease in an infant after hepatitis B vaccination has been described. We report a case of Kawasaki disease in a 2 month-old infant who developed the Kawasaki disease 1 day after receiving his first dose of diphtheria tetanus-acellular pertussis, Haemophilus b and pneumococcal conjugate vaccine.

Keywords

Vaccination; Kawasaki disease; Immunization

Introduction

Kawasaki disease (KD) is an acute, multisystemic vasculitis, manifested by a constellation of signs and symptoms, including fever, rash, conjunctival injections, cervical lymphadenopathy, oral mucosal changes, and characteristic extremity changes. The etiology of KD is unclear [1]. Only rare cases of vasculitis after vaccination have been reported [2-5]. Moreover, the occurrence of KD in the first weeks of life is very rare [6,7]. We report a case of KD in a 2 month-old infant who developed the Kawasaki disease 1 day after receiving his first dose of diphtheria tetanus- acellular pertussis, poliovaccine, Haemophilus b conjugate vaccine (DTaP-IPV-Hib) (Infanrix, GlaxoSmithKline Vaccines) and pneumococcal conjugate vaccine (PCV13) (Prevenar, Pfizer).

Case Report

A 2 month old infant was admitted to the hospital 1 day after receiving his routine 2-month immunizations, including DTaP-IPV-Hib and PCV13 because of fever. Initially this fever was attributed to the vaccination by another department. But, the patient was admitted to our hospital's department of pediatrics after 6 days followed by receiving his vaccination because of generalized rash and high-grade persistent fever not relieved by acetaminophen. On the physical examination, he was febrile and extremely irritable. His vital signs included an axillary temperature of 38.9°C, heart rate of 164 beats per minute, respiratory rate of 46 breaths per minute, and a blood pressure of 74/41 mmHg.

Pharynx was hyperemic. He had strawberry tongue with lip fissures, generalized rash and non-purulent conjunctivitis. Lungs and heart examination was unremarkable. Liver and spleen were within normal limits. Laboratory findings included a white blood cell (WBC) 23400/mm3, hemoglobin 8.2 g/dL, platelets 826000/mm3, C-reactive protein (CRP) 106 mg/L (reference: 0-5 mg/L), erythrocyte sedimentation rate (ESR) 76 mm/hour (reference: <15 mm/hour), albumin 3 g/dl (reference: 3.8-5.4 g/dl), alanin aminotransferaz (ALT) 51 U/L (reference: 0-40 U/L), aspartat aminotransferaz (AST) 73 U/L (reference: 0-40 U/L), The sodium, potassium, and calcium concentrations were normal. Chest roentgenography and electrocardiography revealed normal. Echocardiography showed generalised dilatation of the left and right coronary arteries (Figure 1).

vaccines-vaccination-artery-diameter

Figure 1: An echocardiographic apical anterior and parasternal long axis view during the acute illness showing diffusely dilated left and right main (arrows) coronary arteries. Main left coronary artery diameter was measured 4 mm. Main right coronary artery diameter was measured 3.09 mm. Ao; aorta, LA; left atrium, LV; left ventricle, LCA; left coronary artery, RCA; right coronary artery.

Main left coronary artery diameter was measured 4 mm (range: 0.77-2.03 mm, Z-score: +8.21) and main right coronary artery diameter was measured 3.09 mm (range: 0.55-1.82 mm, Z-score: +6.02). Based on the clinical and cardiac findings, the diagnosis of KD was made. A single dose of intravenous immunoglobulin (IVIG) 2 g/kg was administered. Salicylic acid (80 mg/kg/day) was started. His body temperature returned to normal within 12 hours IVIG administration.

Three days after IVIG administration CRP decreased to 18 mg/L, WBC decreased to 14200/ mm3, platelets increased to 1001000/mm3, albumin increased to 3.4 gr/dl, and ALT -AST returned to normal values. Bacterial cultures performed on admission showed no growth of pathogens. Rectal and nasopharyngeal swabs were sent for adenovirus and enterovirus cultures, and the results were negative. Cytomegalovirus IgM, Epstein-Barr virus capsid IgM, parvovirus IgM antibody screens were also negative. On day 8 of the hospitalization he was discharged home with salicylic acid (5 mg/kg/day). Three months later in follow-up, coronary artery sizes returned to normal values.

Discussion

Vaccinations are usually well tolerated. Common side effects include local itching, myalgia, malaise, headache, lymphadenopathy, bandage reaction, generalized pruritus, fever, local rash and generalized rash [8]. KD can occur in a temporal relationship with vaccination, but a causal association has not been established. Treadwell et al. [9] found no association between KD and vaccination during the 30 days before disease onset. In the literature different subtypes of vasculitis have been repeatedly reported after vaccination [3-5]. However, only one case of KD in a 35-day-old infant 1 day after hepatitis B vaccination has been described [2]. We describe first case, to our knowledge, of KD in a 2 month-old infant with a strong temporal association with the first dose of DTaP-IPV-Hib and PCV13 vaccination. In our case virological and bacterial study findings were negative for bacteria, Coxsackie virus, parvovirus and other enteroviruses. Serologic studies also failed to show elevation of IgM level of viruses. The presence of prolonged fever, rash, conjunctivitis, mucous membrane erythema, increased levels of acute phase reactants (including significant thrombocytosis) and echocardiographic dilation of the coronary artery favor the diagnosis of KD. Moreover, the patient responded promptly to IVIG therapy. The pathogenic mechanism of KD in this infant is not clear. The possible mechanisms of vessel damage after vaccination may be abnormal immunological activation [5]. KD in infancy is rare. In study patients with KD only 1.67% was under 3 months of age and only 6 were less than 30 days of age [6]. In another study there were no cases of KD in infants less than 2.25 months of age [7].

Overall, DTaP-IPV-Hib and PCV13 vaccination are very safe. KD may be a rare side effect of vaccination. Therefore, physicians should be aware of possible serious side effects resulting from vaccination.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12728
  • [From(publication date):
    August-2014 - Dec 12, 2017]
  • Breakdown by view type
  • HTML page views : 8919
  • PDF downloads : 3809
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version